Given that hyperkyphosis is also associated with bone loss and vertebral fractures, the authors of the article «Patterns
of menopausal hormone therapy use and hyperkyphosis in older women» hypothesized that HT may also be effective in helping prevent exaggerated spine curvature, sometimes called dowager's hump.
Among prescriptions filled
for menopausal hormone therapy (HT) in the U.S., almost half now are custom - compounded «bioidentical» hormones, according to analysis of a recent survey of nearly 500 pharmacists.
«The goal of the WHI was to evaluate the balance of benefits and risks of
menopausal hormone therapy when used for prevention of chronic disease,» says JoAnn Manson, a physician epidemiologist at Harvard - affiliated Brigham and Women's Hospital in Boston and one of the lead investigators of the WHI.
Although a large 2002 government study called the Women's Health Initiative (WHI) raised concerns
about menopausal hormone therapy raising the risks of blood clots, stroke, breast cancer and heart attacks in postmenopausal women, additional research conducted in the ensuing years has found that the level of risk depends on the individual woman's health history, age and other factors.
The controversy
around menopausal hormone therapy is based on whether these treatments are designed with synthetic hormones, or from a variety of plants, animals, or made in a lab and their chemical effect on a woman's body.
Breastfeeding for at least six months, planning your first child before age 30, limiting night shift work, and avoiding /
limiting menopausal hormone therapy may also be protective.
PMCID: PMC2219716 Bioidentical Hormones
for Menopausal Hormone Therapy: Variation on a Theme Adriane Fugh - Berman, MD and Jenna Bythrow, MS candidate
Menopausal hormone therapy and health outcomes during intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Menopausal hormone therapy and long - term all - cause and cause - specific mortality.
Menopausal hormone therapy: current considerations.
Researchers at the Kaiser Permanente Center for Health Research in Portland, Ore., concluded there is definitely a link between breast cancer and the use of
menopausal hormone therapy, particularly estrogen - progestin treatment combinations.
They calculated that each year 57 to 75 million prescriptions for
all menopausal hormone therapies are filled.
Some women turned to custom - compounded
menopausal hormone therapy (MHT) because of a misconception that is was safer than FDA - approved treatments.
However, health providers and their patients should understand the differences in and the risks associated with less - regulated treatments of compounded
menopausal hormone therapy,» she stated.
If you still get your period and take
menopausal hormone therapy, you may need more iron than women who are postmenopausal and do not take menopausal hormone therapy.
Another hot topic for the formation of breast cancer risk factors is «
menopausal hormone therapy.»
Menopausal hormone therapy is a treatment that is used for women to help relieve annoying symptoms of menopause and to prevent other biological changes, like bone loss due to the reduction * of estrogen and progesterone.